EDITORIAL SECTION
-
STRATEGY
Smarter Pharma
Quality management systems QMS are the backbone of pharmaceutical manufacturing ensuring safe products
-
RESEARCH DEVELOPMENT
Cytiva Laboratory capsule filters
Our singleuse selfcontained filtration solution
-
CLINICAL TRIALS
Why Clinical Trials Need Digital Endpoints
According Citeline the average success rate for bringing a Phase candidate to market has dropped to an alltime low of just
-
MANUFACTURING
Ensuring Quality and Compliance in Biopharma
Ensuring quality and regulatory compliance in the biopharmaceutical industry is critical to safeguarding product safety and efficacy
-
Information Technology
The Cost of Bad Data
Modern pharmaceutical research generates an unprecedented volume of information Data from genomic sequencing
-
Biopharma
Reimagining Global Biomanufacturing Capacity with Continuous and Modular Systems
Biotechnology is fueling the ongoing expansion of the global market for a broad array of goods
-
EXPERT Talk
Compliance to Competitive Advantage in Pharma Supply
Compliance gets you through an audit Resilience gets medicines to patients on the day something unexpected happens The DSCSAs enhanced requirements took effect November but real interoperability required three more rounds of accommodation phased implementation with the smalldispenser
Advisory Board
KNOWLEDGE BANK
-
Articles
Key Stages in Pharmaceutical Formulation Development: A Complete Guide
One of the most significant operations in the field of drug study is pharmaceutical formulation development to ensure that the medications are distributed to the patients without harm and in the most appropriate manner This is a science that involves the transformation of an active pharmaceutical ingredient API into a solid efficient and convenient dosage form To researchers manufacturers and regu...
Navigating Gene Therapy Regulations: Compliance Strategies for Successful Implementation
Gene therapy holds immense promise for treating a wide range of genetic disorders and diseases However its implementation requires strict adherence to regulatory guidelines to ensure safety efficacy and ethical considerations
Data-Driven Pharma: Enterprise AI Strategies for R&D, Quality, and Operations
Few boardrooms in European pharma still need convincing that artificial intelligence matters The argument has moved on The uncomfortable question now facing chief executives chief scientific officers and heads of operations is why an organisation running eighty or ninety AI initiatives can rarely point to eighty or ninety changes in how it discovers releases or ships a medicine
Optimizing Pharmaceutical Viral Vector Production: Techniques and Challenges
Pharmaceutical viral vectors have emerged as powerful tools in gene therapy vaccine development and biotechnology research The ability of viral vectors to deliver genetic material into target cells
Biopharmaceutical Facility Design for Sustainability: A Comprehensive Overview
The design and operation of biopharmaceutical facilities play a pivotal role in shaping the environmental impact of the pharmaceutical industry In recent years there has been a growing emphasis on sustainability within this sector
Chiral Biosensors: Precision Tools for Safer Drugs
The pharmaceutical industry has long been recognised the profound implications of chirality in drug design and development Enantiomers mirrorimage isomers of a chiral molecule show dramatically distinct pharmacokinetic PK and pharmacodynamic PD profiles One may be therapeutically active while its counterpart could be inactive or harmful As a result the precise detection discrimination and quantifi...
-
Techno Trends
USF Researchers Identify New P. vivax Vaccine Target
Researchers at USF Health have identified a previously unknown vulnerability in Plasmodium vivax a major malaria parasite found across parts of Asia and Central and South America
-
Projects
Evonik Launches US$94 Million (EUR 80 million) Biotechnology Expansion in Slovakia
Evonik has commenced construction of a new biotechnology expansion at its Fermas facility in Slovensk upa Slovakia The development is part of an approximately US million investment EUR million
-
Research Insights
One-month physicochemical stability study of idarubicin prepared in polyolefin-type bags for the treatment of hematological diseases
Idarubicine is a mainstay of the treatment strategy for hematological cancer The literature lacks stability data that comply with current preparation practices and recommendations for conducting stability studies
-
whitepaper
Post-Translational Modifications in Drug Discovery: From Molecular Regulation to Clinical Impact
For decades the central dogma of molecular biology has anchored our understanding of cellular function DNA to RNA to protein But this linear view is incomplete A growing body of evidence shows that much of biologys
TOP ARTICLES
-
1
Navigating Gene Therapy Regulations: Compliance Strategies for Successful Implementation
Kate Williamson
Navigating gene therapy regulations requires a comprehensive approach integrating scientific expertise, regulatory compliance, and ethical considerations. This article explores key compliance strategi...
-
2
Data-Driven Pharma: Enterprise AI Strategies for R&D, Quality, and Operations
Lakshmi
Pharmaceutical enterprises have outgrown the pilot phase of artificial intelligence, yet value remains trapped inside individual functions. This article examines how European pharmaceutical leaders ca...
-
3
Optimizing Pharmaceutical Viral Vector Production: Techniques and Challenges
Kate Williamson
This article explores techniques and challenges in optimizing pharmaceutical viral vector production for gene therapy and vaccine development. Topics include vector design, cell culture, purification,...
-
4
Biopharmaceutical Facility Design for Sustainability: A Comprehensive Overview
Kate Williamson
This comprehensive overview explores the sustainable design of biopharmaceutical facilities, emphasizing key considerations such as green building design, energy efficiency, water conservation, waste...
-
5
Chiral Biosensors: Precision Tools for Safer Drugs
Dr. Selvakumar Kanthiah
Dr. Valliappan Kannappan
In drug development, identifying the right mirror-image molecule - called an enantiomer - can be the difference between a life-saving treatment and unwanted side effects. Chiral biosensors are revolut...
press releases Read more...
Walden Biosciences to Present Phase 1+ and Phase 2 Data for WAL0921 at American Society of Nephrology Kidney Week
Walden Biosciences Inc Walden or the Company a private clinicalstage biotechnology company dedicated to developing diseasemodifying medicines to treat rare chronic kidney diseases
Century Therapeutics' CNTY-813 Demonstrates Continued Advancement Toward the Clinic Via Nonclinical Data Presented at EASD 2026
Century Therapeutics Inc Century NASDAQ IPSC a biotechnology company developing induced pluripotent stem cell iPSCderived cell therapies for type diabetes TD and other autoimmune
Thewaico Emerges from Stealth with Bioreactor Platform Built to Address Biomanufacturing's Massive Scale-Up Problem
Thewaico a bioprocess innovation company today emerged from stealth with an integrated bioreactor and bioprocess control platform developed to address one of biomanufacturings most persistent and costly failures
Seasoned Biotech Finance Executive Florian Schmid Appointed CFO of T-CURX to Support Next Phase of Growth
TCURX GmbH TCURX a biotechnology company developing nonviral CART therapies today announced the appointment of Florian Schmid as Chief Financial Officer Florian will lead the company
Events Read more...
05 - 06
Oct 2026ISPSAI France 2026
Paris, France
05 - 08
Oct 202616th World CB & CDx Summit 2026
Boston, MA, USA
12 - 13
Oct 2026Pharmaceutics 2026
Village Hotel Changi, Singapor...
12 - 13
Oct 20262nd International Conference on Drug Discovery
Village Hotel Changi, Singapor...
21 - 23
Oct 2026Drug Formulation & Drug Delivery 2026
Paris, France
21 - 22
Oct 2026Advance Clinical Trials and Research 2026
Paris, France
22 - 23
Oct 2026PDA Aseptic Symposium 2026
Congress Square Nakanoshima, O...
26 - 28
Oct 2026ACHEMA Middle East 2026
RICEC, Riyadh, KSA, Saudi Arab...
LATEST NEWS Read more...
Quotient Sciences and Acesion Pharma collaborate on AI-enhanced formulation development
Quotient Sciences and Acesion Pharma have announced a collaboration to use AIenhanced formulation development to support Acesions earlystage pipeline of smallmolecule treatments for atrial fibrillation
Fresenius completes acquisition of mAbxience
Fresenius SE Co KGaA has completed the acquisition of the remaining stake in mAbxience from Insud Pharma giving Fresenius full ownership of the biopharmaceutical company
R1 Therapeutics expands Series A financing to $80.5 million
R Therapeutics has expanded its Series A financing to million with new investment from Samsara BioCapital The clinicalstage biopharmaceutical company will use the funding to advance AP
Immunome receives FDA clearance for IM-1340 clinical trial
Immunome has received clearance from the US Food and Drug Administration FDA for its Investigational New Drug IND application for IM an investigational antibodydrug conjugate ADC being developed for advanced solid tumours
Novonesis Expands West Allis Facility to Strengthen North American Dairy Production
Novonesis has completed a major expansion of its production facility in West Allis Wisconsin increasing its North American capacity for dairy cultures The investment has raised fermentation capacity
4basebio and TriLink BioTechnologies Partner to Support Phase I Cell Therapy Programme
basebio has announced a partnership with TriLink BioTechnologies to support a Phase I cell therapy programme being developed by a multinational pharmaceutical company




